ZTS Q3 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.8B+12.8% YoY

Gross Profit

$1.2B67.2% margin

Operating Income

$664M37.2% margin

Net Income

$479M26.8% margin

EPS (Diluted)

$1.00

QoQ Revenue Growth

+15.4%

Cash Flow

Operating Cash Flow

$562M

Free Cash Flow

$437M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$13.7B

Total Liabilities

$10.1B

Stockholders' Equity

$3.6B

Cash & Equivalents

$3.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.6B	+12.8%
Gross Profit	$1.2B	$1.1B	+12.5%
Operating Income	$664M	$564M	+17.7%
Net Income	$479M	$433M	+10.6%

Revenue Segments

Dogs and Cats

$947M55%

Cattle

$417M24%

Swine

$151M9%

Poultry

$129M7%

Horses

$48M3%

Fish

$45M3%

Geographic Segments

United States Segment

$996M56%

International Segment

$767M44%